CMS Reaffirms Federal Preemption Over Medicare Advantage Broker Compensation
CMS memo confirms federal law supersedes state regulation of Medicare Advantage broker compensation and marketing, impacting insurer practices and legal disputes.
CMS memo confirms federal law supersedes state regulation of Medicare Advantage broker compensation and marketing, impacting insurer practices and legal disputes.
California faces a potential surge in ACA premiums if Congress fails to extend subsidies set to expire, risking affordability for 400,000 enrollees. Bipartisan efforts focus on reform and maintaining coverage amid political challenges.
MedPAC recommends a 7% cut to Medicare home health payment rates in 2027 amid stable agency margins and concerns over program integrity and Medicare Advantage impacts.
Blue Cross and Blue Shield of Minnesota resolves contract dispute with Aspirus Health, maintaining St. Luke’s Hospital in network for Medicare Advantage members and ensuring network continuity amid broader insurer-provider negotiations in Minnesota.
Humana shifts strategy as it revises earnings outlook and explores pharmacy partnership to innovate Medicare Advantage offerings and expand margins.
H.R. 5371 temporarily extends key Medicare telehealth flexibilities through January 2026, restoring pandemic-era policies and directing CMS to update claims processing guidance.
Aetna integrates pharmacy prescriptions with medical procedure prior authorizations to streamline healthcare approvals and enhance payer-provider efficiency through AI-driven digital tools.
Explore key trends and regulatory updates in Medicare Supplement and Medicare Advantage plans affecting premiums, enrollment, and insurer market exits. Insights for insurance professionals and brokers.
Jefferies upgrades Humana following success in Medicare Advantage portfolio diversification and higher Star Ratings, projecting strong earnings growth for 2026 and 2027 amid regulatory challenges.
Explore Medicare coverage guidelines for Botox focusing on FDA-approved medical uses, prior authorization, medical necessity, and cost factors under Medicare Part B and Advantage plans.